{"ticker": {"uuid": "eb0b693c-3e26-4e10-8f9c-e252829091da", "symbol": "PRCT", "name": "Procept Biorobotics Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Procept Biorobotics Corp stock hits 52-week low at 19.2 USD", "summary": "Procept Biorobotics Corp (PRCT) stock has fallen to a new 52-week low of $19.21, marking a significant 63.52% decline over the past year. Despite this downturn and a market capitalization of $1.21 billion, InvestingPro indicates the stock may be undervalued with a Fair Value esti", "url": "https://ng.investing.com/news/stock-market-news/procept-biorobotics-corp-stock-hits-52week-low-at-192-usd-93CH-2599101", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T22:40:51", "published_display": "14 Jul 2026 22:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics to report Q2 2026 results on August 4", "summary": "PROCEPT BioRobotics Corporation will release its financial results for the second quarter of 2026 after the market closes on August 4, 2026. Following the release, the company will host a conference call at 4:30 p.m. Eastern Time to discuss their performance. A live webcast and a", "url": "https://scanx.trade/stock-market-news/companies/procept-biorobotics-to-report-q2-2026-results-on-august-4/45613228", "source_name": "scanx.trade", "published_at": "2026-07-14T22:14:42", "published_display": "14 Jul 2026 22:14", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Procept Biorobotics Corp stock hits 52-week low at 19.2 USD By Investing.com", "summary": "Procept Biorobotics Corp (PRCT) stock has reached a 52-week low of $19.21, marking a significant 63.52% decline over the past year. Despite the downturn, InvestingPro analysis suggests the stock might be undervalued with a Fair Value estimate of $28.01. Recent news indicates the ", "url": "https://za.investing.com/news/stock-market-news/procept-biorobotics-corp-stock-hits-52week-low-at-192-usd-93CH-4368466", "source_name": "Investing.com South Africa", "published_at": "2026-07-14T22:14:42", "published_display": "14 Jul 2026 22:14", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics\u00ae to Report Second Quarter 2026 Financial Results on August 4th, 2026", "summary": "PROCEPT BioRobotics Corporation (Nasdaq: PRCT) announced it will report its Q2 2026 financial results after market close on Tuesday, August 4, 2026. The company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results. Interested parties can access", "url": "https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/procept-biorobotics-to-report-second-quarter-2026-financial-results-on-august-4th-2026/2384531/amp", "source_name": "The Manila Times", "published_at": "2026-07-14T20:14:42", "published_display": "14 Jul 2026 20:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hear PROCEPT BioRobotics\u2019 Q2 update Aug. 4 at 4:30 p.m.", "summary": "PROCEPT BioRobotics (Nasdaq: PRCT) announced it will report its second-quarter 2026 financial results after market close on Tuesday, August 4, 2026. Management will host a conference call at 4:30 p.m. Eastern Time, which will be accessible via webcast and archived for at least 90", "url": "https://www.stocktitan.net/news/PRCT/procept-bio-robotics-to-report-second-quarter-2026-financial-results-muc8mzbia14w.html", "source_name": "Stock Titan", "published_at": "2026-07-14T19:40:11", "published_display": "14 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)", "summary": "Truist Financial analyst Richard Newitter maintained a Hold rating on PROCEPT BioRobotics (PRCT) and set a price target of $25.00. The company reported a quarterly revenue of $83.13 million and a GAAP net loss of $31.64 million, with analyst consensus remaining a \"Moderate Buy.\" ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/PRCT/pressreleases/3175609/truist-financial-sticks-to-its-hold-rating-for-procept-biorobotics-prct/", "source_name": "The Globe and Mail", "published_at": "2026-07-08T20:10:34", "published_display": "08 Jul 2026 20:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/truist-downgrades-procept-biorobotics-hold-094929142.html", "source_name": "MT Newswires", "published_at": "2026-07-06T09:49:29+00:00", "published_display": "06 Jul 2026 09:49", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRCT - Procept BioRobotics Corp Dividends", "summary": "This article provides a detailed financial overview of Procept BioRobotics Corp (PRCT), including its latest stock performance, key financial metrics, and insider transaction data. It highlights the company's current stock price, recent percentage change, market capitalization, a", "url": "https://finviz.com/stock?t=PRCT&p=m&b=2&ty=dv", "source_name": "Finviz", "published_at": "2026-07-03T18:09:46", "published_display": "03 Jul 2026 18:09", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Securities downgraded the stock rating of PROCEPT BioRobotics Corp from \"Buy\" to \"Hold\"", "summary": "Truist Securities has downgraded PROCEPT BioRobotics Corp's stock rating from \"Buy\" to \"Hold\" and significantly reduced its target share price from $30 to $25. This decision reflects a re-evaluation by the institution regarding the company's investment prospects. The article also", "url": "https://www.bitget.com/amp/news/detail/12560605488358", "source_name": "Bitget", "published_at": "2026-07-03T05:40:15", "published_display": "03 Jul 2026 05:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Procept Biorobotics Corp (PRCT)", "summary": "This article analyzes the historical performance of Procept Biorobotics Corp (PRCT) stock, detailing how a $1,000 investment would have fared over different periods. It also provides an overview of the company's focus on surgical robotics for urology, specifically its AQUABEAM an", "url": "https://www.stocktitan.net/tools/stock-return-calculator/PRCT", "source_name": "Stock Titan", "published_at": "2026-07-03T00:09:46", "published_display": "03 Jul 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist cuts Procept BioRobotics stock rating on reimbursement concerns", "summary": "Truist Securities downgraded Procept BioRobotics Corp (NASDAQ:PRCT) to Hold from Buy and lowered its price target due to concerns over reimbursement for its Aquablation procedures. This downgrade follows a proposal from the Centers for Medicare and Medicaid Services to increase r", "url": "https://www.investing.com/news/analyst-ratings/truist-cuts-procept-biorobotics-stock-rating-on-reimbursement-concerns-93CH-4774243", "source_name": "Investing.com", "published_at": "2026-07-02T21:39:19", "published_display": "02 Jul 2026 21:39", "sentiment": "negative", "sentiment_pct": 27, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of PROCEPT BioRobotics Corp. \u2013 BX:PRCT", "summary": "This page displays the enterprise value to EBIT forward for PROCEPT BioRobotics Corp. (BX:PRCT). It is part of the financial data available for the company on the platform. The information is provided by various financial data services.", "url": "https://www.tradingview.com/symbols/BX-PRCT/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T08:09:50", "published_display": "02 Jul 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Is Up 7.2% After WATER IV Milestones Spotlight Aquablation\u2019s Oncology Potential \u2013 Has The Bull Case Changed?", "summary": "PROCEPT BioRobotics (PRCT) saw its stock rise by 7.2% following milestones in its WATER IV prostate cancer trials, suggesting Aquablation therapy could expand into urologic oncology. This development could broaden the company's market beyond benign prostatic hyperplasia, reinforc", "url": "https://www.sahmcapital.com/news/content/procept-biorobotics-prct-is-up-72-after-water-iv-milestones-spotlight-aquablations-oncology-potential-has-the-bull-case-changed-2026-07-01", "source_name": "Sahm", "published_at": "2026-07-01T05:41:27", "published_display": "01 Jul 2026 05:41", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Initiates PROCEPT BioRobotics (PRCT) At \u201cOutperform,\u201d Cites Aquablation Growth Potential", "summary": "Evercore ISI has initiated coverage on PROCEPT BioRobotics (PRCT) with an \"Outperform\" rating and a $30 price target, highlighting the potential of Aquablation therapy. The company recently achieved two significant milestones in its WATER IV prostate cancer clinical program, incl", "url": "https://www.insidermonkey.com/blog/evercore-initiates-procept-biorobotics-prct-at-outperform-cites-aquablation-growth-potential-1790977/?amp=1", "source_name": "Insider Monkey", "published_at": "2026-06-30T02:10:35", "published_display": "30 Jun 2026 02:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of PROCEPT BioRobotics Corp. \u2013 BX:PRCT", "summary": "This article provides financial data for PROCEPT BioRobotics Corp. (BX:PRCT), specifically focusing on its price-to-earnings forward metric. The content highlights the period, value, and change percentage of this financial indicator, noting that the data is provided by ICE Data S", "url": "https://www.tradingview.com/symbols/BX-PRCT/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T05:09:32", "published_display": "28 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of PROCEPT BioRobotics Corp. \u2013 BX:PRCT", "summary": "This article provides the \"Price to sales forward\" financial metric for PROCEPT BioRobotics Corp. (BX:PRCT) on the TradingView platform. It shows the company's ticker, exchange, and confirms that the market is currently closed with no trades. The data presented is stated as being", "url": "https://www.tradingview.com/symbols/BX-PRCT/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T02:39:52", "published_display": "28 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRCT Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for PROCEPT BioRobotics Corp. (PRCT) stock, based on analyst opinions. It highlights the current stock price, market capitalization, volatility, and details on past earnings, revenue, and upcoming earnings reports. Additionally, i", "url": "https://www.tradingview.com/symbols/BIVA-PRCT/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-28T01:10:50", "published_display": "28 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of PROCEPT BioRobotics Corp. \u2013 BX:PRCT", "summary": "This page displays the \"Price to book forward\" financial metric for PROCEPT BioRobotics Corp. (PRCT) on the BX Swiss exchange. It indicates that the financial data is 'Made by humans' and sources its market and reference data from ICE Data Services and FactSet, respectively. The ", "url": "https://www.tradingview.com/symbols/BX-PRCT/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T01:10:50", "published_display": "28 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BIOROBOTICS CORP (PRCT) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE1tQW9mRGVEeENaUGx1S0xrUFN2cV83Z1VPcjdFVzNvdnE5anp6VHZwaGJSSG9lQ19QVkVwdWQyQzEtcVBneFhhRUdyTUwxOHZHckd1YWJIMmdJS01QSlF0Wm9vRy0?oc=5", "source_name": "ChartMill", "published_at": "2026-06-27T00:21:28+00:00", "published_display": "27 Jun 2026 00:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right Now", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/why-procept-biorobotics-prct-amongst-060211529.html", "source_name": "Insider Monkey", "published_at": "2026-06-25T06:02:11+00:00", "published_display": "25 Jun 2026 06:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI initiates Procept BioRobotics stock with outperform rating", "summary": "Evercore ISI initiated coverage on Procept BioRobotics (NASDAQ:PRCT) with an outperform rating and a $30 price target, highlighting the company's strong long-term fundamentals despite short-term challenges. The firm believes Procept's Aquablation technology has superior clinical ", "url": "https://m.uk.investing.com/news/stock-market-news/evercore-isi-initiates-procept-biorobotics-stock-with-outperform-rating-93CH-4742028?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-25T02:10:48", "published_display": "25 Jun 2026 02:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Initiates Coverage on PROCEPT BioRobotics With Outperform Rating, $30 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/evercore-isi-initiates-coverage-procept-112650225.html", "source_name": "MT Newswires", "published_at": "2026-06-24T11:26:50+00:00", "published_display": "24 Jun 2026 11:26", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI initiates Procept BioRobotics stock with outperform rating By Investing.com", "summary": "Evercore ISI has initiated coverage on Procept BioRobotics (NASDAQ:PRCT) with an outperform rating and a $30.00 price target, citing the company's strong long-term fundamentals despite short-term challenges. The firm believes Procept's Aquablation technology has superior clinical", "url": "https://ca.investing.com/news/stock-market-news/evercore-isi-initiates-procept-biorobotics-stock-with-outperform-rating-93CH-4705021", "source_name": "Investing.com Canada", "published_at": "2026-06-24T10:40:17", "published_display": "24 Jun 2026 10:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Best Robotics and Automation Stocks to Invest In", "summary": "This article lists the top 5 robotics and automation stocks to consider for investment, highlighting PROCEPT BioRobotics Corp. as one of them. PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is praised for its advancements in prostate cancer treatment with its Aquablation therapy, partic", "url": "https://www.insidermonkey.com/blog/5-best-robotics-and-automation-stocks-to-invest-in-1787445/?amp=1", "source_name": "Insider Monkey", "published_at": "2026-06-24T03:30:00", "published_display": "24 Jun 2026 03:30", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20", "summary": "Bank of America has downgraded PROCEPT BioRobotics (PRCT) to 'Underperform' from 'Neutral' and cut its price target to $20 from $38, following the company's Q4 results which missed street estimates. Concerns were raised about earnings visibility, profitability, and execution, as ", "url": "https://stocktwits.com/news-articles/markets/equity/prct-stock-tumbles-pre-market-bof-a-questions-earnings-visibility-cuts-target-to-20/cZTGJmTRIbn", "source_name": "Stocktwits", "published_at": "2026-06-23T04:10:27", "published_display": "23 Jun 2026 04:10", "sentiment": "negative", "sentiment_pct": 20, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed?", "summary": "PROCEPT BioRobotics (PRCT) has experienced a 6.5% stock drop despite strong year-over-year revenue and net profit growth, coupled with a surge in institutional ownership exceeding total shares outstanding. The company's investment narrative centers on Aquablation becoming a stand", "url": "https://www.sahmcapital.com/news/content/procept-biorobotics-prct-is-down-65-after-institutional-ownership-surges-past-shares-outstanding-has-the-bull-case-changed-2026-06-23", "source_name": "Sahm", "published_at": "2026-06-22T13:40:17", "published_display": "22 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds", "summary": "Despite a recent stock decline, PROCEPT BioRobotics (PRCT) is considered 14% undervalued with a fair value of $25.26 per share, even though it currently trades at $21.72. Analyst commentary highlights rapid revenue growth, expanding gross margins, and lower management guidance. A", "url": "https://www.sahmcapital.com/news/content/procept-biorobotics-prct-stock-could-be-14-undervalued-after-growth-outlook-holds-2026-06-20", "source_name": "Sahm", "published_at": "2026-06-20T12:40:07", "published_display": "20 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPaVdpLVpqUGNzRkNyZDZHYk1WZE9NNmRGNjNxV0hRSzFHNW5jbmVac2FoZXFBMDBFUS1BdDF6eXd6dmVlZDF4a0hyYUhCVW9kOXljckFLRWNuNU5sNGNVUjB5c3NjcEpRU2NmLXJYcENocEFRMG5WcnlFc20wemM4eHF4a29vbHphVFlTREU3VVdEd3NZTmU4OUtrVEJBTW1jUjlVX2VZblQtUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top 3 Health Care Stocks You'll Regret Missing In Q2", "summary": "This article identifies three oversold health care stocks\u2014iRhythm Holdings, Anbio Biotechnology, and Procept Biorobotics\u2014that investors might regret missing in Q2. These companies are highlighted based on their Relative Strength Index (RSI) being near or below 30, indicating a po", "url": "https://www.sahmcapital.com/news/content/top-3-health-care-stocks-youll-regret-missing-in-q2-2026-06-18", "source_name": "Sahm", "published_at": "2026-06-19T00:09:30", "published_display": "19 Jun 2026 00:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Procept Biorobotics Corp (PRCT) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Procept Biorobotics Corp (PRCT), listing its major institutional holders like Fidelity Management & Research Company LLC, BlackRock, and AllianceBernstein. It provides a breakdown of shareholder types, institutional shareholding t", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prct/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T23:17:54", "published_display": "17 Jun 2026 23:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Procept Biorobotics Corp (PRCT) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Procept Biorobotics Corp (PRCT), detailing its current earnings forecast score, analyst ratings, and price targets. PRCT ranks 142 out of 203 in the Healthcare Equipment & Supplies industry with a \"Buy\" trend based on 15 analysts, and", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prct/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T20:40:24", "published_display": "17 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Procept Biorobotics stock sliding today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOeExtVmRLcGRJektYeUFETWtvLU0yV0VSV3MwRlZCaTJGRTRpS254bHhTang3dmFmenNSUkROZ0JFZmRFb3VoM2FRbTdPa1FvaDlId280VFUwMDh1cUtBZ1cyblJ1alROT2ZhNWR4QkU5MGJ5WE9aa3RpQUxhUnEtTUNtWHIyWFk1T1NkV29ET0N5c2o0QWhzSmplQlhCcnhuZ0I1c0N1a2ptaVl1?oc=5", "source_name": "Investing.com", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "PROCEPT BioRobotics Shares Drop After Downgrade From Leerink Partners", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/procept-biorobotics-shares-drop-downgrade-181932865.html", "source_name": "MT Newswires", "published_at": "2026-06-11T18:19:32+00:00", "published_display": "11 Jun 2026 18:19", "sentiment": "negative", "sentiment_pct": 42, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) director receives RSU and option grants as equity pay", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQLXZUcmxjMDY4MFZiNG1aT2RuZ1JWdzVrMEZVdzhTbEhXSGJDOVJmTjRRUTl6N29OTU1Vc3BHN095d1ZJVHVqUDkyNTNOV1hwcWlEeGRWM0VWZ0F5UHV0WDY2S3A5VVlPZlVOWTNGQ1hMMGpyMHBfMTRuNUdIdGRXUUpXcVpUdU5LNVU3cFdybUFEYi1VbTQ0RnQtbTNoS1BpNUlFOXFzZU9mMFpySXZCNFR5SW9sQV82eldN?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Amy Dodrill receives RSUs and options at PROCEPT (NASDAQ: PRCT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNRkt6X3FYbDQ1ZzdmTTlIX1pZa2xkWUhzRU0xVHMxaDJsVS1lN3BsbENjN29xaUVKNFoyTnI5MmNUUDBRalFRdWM4MnV5YkJJUk13bnQ5dVVVLThPTTJjaE1DbHF2SDRZSnA3YTVJUlZFTGNaMlRNcjhQT0tEaXVyNFRieVNvTDdEVmJ2T2k3bl9LRkdRNDduenhoQkFDbWpEMDN1Ym5uR085dkE5cXk3ZnoxOGJ1emEwNE1v?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV Milestones - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQSm9RamlsWXlDZmhCN01FMWpEbEhKOFlFdWlVUk5NbVRhd3NvR21iUnNGOEpoS296MTljanFYSGJGTmNabUVCcGhkWGJ2QnJUNWVmanh5MGgxaFlkZHU1Unp5VE0wNkk5R3FLR1NwbTZIUlNiSmdLSWdjQV9OU1E2N0VxWFVxVEVrc3BYZWRqblNlbm5zRUV0VVNTZWRaemF5cXc?oc=5", "source_name": "Market source", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPaDZ0RVIwZHNGT29pNXJwVGRFU1oySGpDY2hpazVFbEt1bDFUczF5VmtMVGU3MmlGZnFkQTRlSnBFaE41Uk1jYzJja0FkeVE5WDJIYzd1MHA5RlpBd09mb0ZWZ1AxMk1FbXZCeHk3QUQxd2xpbldzZFAtX0F3WXhFNjRQLU1wTVdKaFZ0QWJ6VGxsUmdMSUljTk45ZXIzd1YtU3ZhV3RJbWpUNVprSklF?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Results Say a Lot About Procept Biorobotics Corp (PRCT) Stock Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQN05oTzBBVk53RnU3S0xQRXljQkJHTHAwVTdlNDJ6Unk4aWJ2RkZ1YjZFMWYzQ25uMlhRVGlYRmtqVmJkejFNNjhEdXhwczNtMWczRlpEUmdhR3dUb1V5SlhaXzhQdjJPZmlHdmQ0UU53RFBtdXZtUDVEWEt4UXh6bHF2R2J2RF9NbFc1aGg4RndjeTNnZGhWTUwySjRIb0dy?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics schedules 3 investor conference appearances", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPWVhnQi1iYnhvYUtSaFIxVzBuZlBJU3Fha3d4SlFMX2sxUTdZRHZlM1RlcDlfTEtuMkNDRFVZNDFMVkYxbnB6YWhkNjdhZjB1RFltbHdhcGU1YlgzemU1aVhaVkdhWUFhQzNyTlptSklqcnNuUHV3ZU5BN3l4bkVpX0ZQTVBleVkzLUp0MzhsS1Y5R0FYcUlJQlRBai1CX3c3bUhwYTlPMGlSVUFpNmdHdEhRY1RSWG1VNG51bHR3?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNb1BRZ3dYS1VZVklMQ0JIYTZyLXl1dncwOWswRnlDcHZRTkdKU3c4RXNUaHdOeE9XQkNtWmFrVWZnYW5GQW81d0dvcU5Cc0FZWS1rQWs2bmxXRlNKR0xNRkhDQm9OdktrRFl2LWNRNU5NNmlwZWtZVnZJZHdRd3NibWplSVRwazBYcTBWYlBweGI5X0ZHUWMtY0hLM0lqTHRQMjc0ZUJyTV9nQWVlVV9VUWE4Qm9ZRFpYc2pyNmkzWHZLb0NYcE9sWC1tU2hRNGw3Wnc?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPdTFnTzlrTndFNHJpR01tN0llNWUwZmtEeExSS0tZdkhsSEVvQy1UcGdHRjJNSE11UHgzS05RSHhyWXo5Tmd5S2RTb2lnRm5uZG9va0ctbkZwNzJuQWlCbXR5WWtlSzd6Tnd0aGZXOXowaTJfdFk3S3FSZlRmVkhScm9Qa25UQjlrQTdKMlNjQ2M3d1ZQSzNPdW5IU0o0ZkZ3UU5ST2FFUl95R3NpOGhqazFmMA?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQZXhDWktWZlhhSHlxNVZrNWllaDhhWlNXZmhKYlQ4ODRJMHozNTR2TVVKSWVrQV94bzNNU0hfVW5qODRlWW01anFmTG5SYmZoUlJpU09UbkpSemxVbHRGb1F1MGVvZFdqSEVBcUZ5Ti1ZVHlzY3pZYTdCS21RcDJPTnppdWRKVlZjd2ZUeA?oc=5", "source_name": "Market source", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "PROCEPT BioRobotics Resets Commercial Model To Pursue Higher Quality Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At PROCEPT BioRobotics (PRCT) Valuation After Q4 Revenue Miss And Softer 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQd1VPVVQwX0ctcnpXc0xoZzg0NHRUNXJyQ0p1UnhaazhBWUNRZG5PTUxnUVJFSnd3U19BYktRNFMtc2RoWHduMjlma2wyaHg5MHJfcTFBemlsNGFZNDlaeUU4em01MFFib2h0S1ZSZDdfbmNZcFBRY0xydThzMVQ1cWdyTUMxUDc4QUdOWmVB?oc=5", "source_name": "Market source", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Details Growth Strategy and Financial Outlook During 2026 Investor Day Event", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQd3pvd1U5cWdaZUlKMGJEX0dkRUVPX3dwWG9jaUFSbi12STQxbGEzTUZjNkgwM09LUXVWbk9nMmt2NnpMUEt1bEd6VzNPNFo3NkVPY3A5eXEtbWVHeS1DbVNPamJvUVpqa0djajh4aXRnZG1JaEM4NW1MT1Y0VkI3RFU0ZkcwQVUzRHRsRE9BeURzcGswT1R3bVFsaGtxLW9BODZrMDNmR2Rwa3c1bFFCczZFdjhibFZEYXZ2TXdmeDhHVVlCZ3lCVg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQSFJDeEhkanRlbzc0TktkcHZvbVVPRm55ejZKOW1zdEw0YzY5R25kV0dRY1JRV3ZJbTdPYl85QkVjZDFXbGhTQ1VrT0V5eUxVMmhVRENBeVZ5OEtvR0NrQl95X1V4ODBjQ1YtMS1mY0pHYkwwZEMxV2N0UFA2MHExb1R4UmpTZURnMTE2S184dUw3RmZKNThRc3czLTRRM05WaHR5aU5jUk9tMmZRN1RiV0pUWHZFTVVFMUVyZWFnUVFwX2xyT3p1cldYVUp0bkdoX0NIaWNZbGlxdDhYc3FZUS1HNUo1Z21BZUdpTUhHaG10QVFidUt4VGpLdkZPaWIt?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Corporation (PRCT): A Bull Case Theory", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNeFRiMkxWV2NmR05iRXlNNmNJV0FNNURYck9USXNkYWFuVHpjREZQRGU3ZnlvQ1BNNVZqSmNTem1wYnNjX001YmZHMEZXdjJwNWN1NXBKcGtIcVFRU0RfZTlERUJRUGk5UExTX2FhaUhQTWVhbU44bzF5Z0JETld5RndIaTMybnMxUTVDVWRfbVI?oc=5", "source_name": "Market source", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Has a Positive Opinion on \u200bPROCEPT BioRobotics (PRCT), Here\u2019s Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQRjZ0TDcwRFNYYWRLZ1ZkZTdtQUYxSHVsSFRXc0tDdlF2ZjluOVVRM0JIckRFOVl2THJRM2cwZ19ONUROaklZMWxLaFpQSGlVeng5dnNJMEw5Sy1tNWpuN0lfakFGcWNGSlZRTThqYktWc1dyRXlMeHJ3MW5OZ1ZyRDFWT3ZMVlYzRUE?oc=5", "source_name": "Market source", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At PROCEPT BioRobotics (PRCT) Valuation After Mixed Recent Share Price Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPWHFMMVg1QWROWHVGb2JUcy1meUhpWDJpN1ZYdGlaT0lRVWgtZWxYNkxETjZoLUlmbDE2ak5EcU5pSlRRTV9kME9CZkNkTlVFVjM3bTF0djUtWThrT2NKMkp1OHlvRTF3S2tXYlJDSzQzY3BfaWZmeTk2YjV3SFRNYzl1YWo5aERKMklfQXd3?oc=5", "source_name": "Market source", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics to Report Q4 2025 Financial Results and Host Investor Day Event in February 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNQXVUOWlrdm91dmY5N2dhWjdiaU10a1dPTU1DY3ZmUHVYaXJKV1VTOXEtRXJrV0kycEx4eHh5MjJRMFpWTDhSTGplZ05ybnJSXzFDcW1Za2YxeW5FeXZRRlZRZHJTbmVtd3NvNXZreFV2d3gtODJ2NlNnWXVJbG9PVEs1ekJyM0FEQlNXQ1VoRVNESFcyUUNhSWZTbllTV1R1S0VtX2NOVnFNM1MzcnNJQWlxX1hxYTZfYmJfSnV3dl9jYm9oaEFQaXVoNkFyUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-01-26T08:00:00+00:00", "published_display": "26 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Procept Biorobotics Corp stock hits 52-week low at 19.2 USD", "summary": "Procept Biorobotics Corp (PRCT) stock has fallen to a new 52-week low of $19.21, marking a significant 63.52% decline over the past year. Despite this downturn and a market capitalization of $1.21 billion, InvestingPro indicates the stock may be undervalued with a Fair Value esti", "url": "https://ng.investing.com/news/stock-market-news/procept-biorobotics-corp-stock-hits-52week-low-at-192-usd-93CH-2599101", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T22:40:51", "published_display": "14 Jul 2026 22:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics to report Q2 2026 results on August 4", "summary": "PROCEPT BioRobotics Corporation will release its financial results for the second quarter of 2026 after the market closes on August 4, 2026. Following the release, the company will host a conference call at 4:30 p.m. Eastern Time to discuss their performance. A live webcast and a", "url": "https://scanx.trade/stock-market-news/companies/procept-biorobotics-to-report-q2-2026-results-on-august-4/45613228", "source_name": "scanx.trade", "published_at": "2026-07-14T22:14:42", "published_display": "14 Jul 2026 22:14", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Procept Biorobotics Corp stock hits 52-week low at 19.2 USD By Investing.com", "summary": "Procept Biorobotics Corp (PRCT) stock has reached a 52-week low of $19.21, marking a significant 63.52% decline over the past year. Despite the downturn, InvestingPro analysis suggests the stock might be undervalued with a Fair Value estimate of $28.01. Recent news indicates the ", "url": "https://za.investing.com/news/stock-market-news/procept-biorobotics-corp-stock-hits-52week-low-at-192-usd-93CH-4368466", "source_name": "Investing.com South Africa", "published_at": "2026-07-14T22:14:42", "published_display": "14 Jul 2026 22:14", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics\u00ae to Report Second Quarter 2026 Financial Results on August 4th, 2026", "summary": "PROCEPT BioRobotics Corporation (Nasdaq: PRCT) announced it will report its Q2 2026 financial results after market close on Tuesday, August 4, 2026. The company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results. Interested parties can access", "url": "https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/procept-biorobotics-to-report-second-quarter-2026-financial-results-on-august-4th-2026/2384531/amp", "source_name": "The Manila Times", "published_at": "2026-07-14T20:14:42", "published_display": "14 Jul 2026 20:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hear PROCEPT BioRobotics\u2019 Q2 update Aug. 4 at 4:30 p.m.", "summary": "PROCEPT BioRobotics (Nasdaq: PRCT) announced it will report its second-quarter 2026 financial results after market close on Tuesday, August 4, 2026. Management will host a conference call at 4:30 p.m. Eastern Time, which will be accessible via webcast and archived for at least 90", "url": "https://www.stocktitan.net/news/PRCT/procept-bio-robotics-to-report-second-quarter-2026-financial-results-muc8mzbia14w.html", "source_name": "Stock Titan", "published_at": "2026-07-14T19:40:11", "published_display": "14 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)", "summary": "Truist Financial analyst Richard Newitter maintained a Hold rating on PROCEPT BioRobotics (PRCT) and set a price target of $25.00. The company reported a quarterly revenue of $83.13 million and a GAAP net loss of $31.64 million, with analyst consensus remaining a \"Moderate Buy.\" ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/PRCT/pressreleases/3175609/truist-financial-sticks-to-its-hold-rating-for-procept-biorobotics-prct/", "source_name": "The Globe and Mail", "published_at": "2026-07-08T20:10:34", "published_display": "08 Jul 2026 20:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/truist-downgrades-procept-biorobotics-hold-094929142.html", "source_name": "MT Newswires", "published_at": "2026-07-06T09:49:29+00:00", "published_display": "06 Jul 2026 09:49", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRCT - Procept BioRobotics Corp Dividends", "summary": "This article provides a detailed financial overview of Procept BioRobotics Corp (PRCT), including its latest stock performance, key financial metrics, and insider transaction data. It highlights the company's current stock price, recent percentage change, market capitalization, a", "url": "https://finviz.com/stock?t=PRCT&p=m&b=2&ty=dv", "source_name": "Finviz", "published_at": "2026-07-03T18:09:46", "published_display": "03 Jul 2026 18:09", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Securities downgraded the stock rating of PROCEPT BioRobotics Corp from \"Buy\" to \"Hold\"", "summary": "Truist Securities has downgraded PROCEPT BioRobotics Corp's stock rating from \"Buy\" to \"Hold\" and significantly reduced its target share price from $30 to $25. This decision reflects a re-evaluation by the institution regarding the company's investment prospects. The article also", "url": "https://www.bitget.com/amp/news/detail/12560605488358", "source_name": "Bitget", "published_at": "2026-07-03T05:40:15", "published_display": "03 Jul 2026 05:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Procept Biorobotics Corp (PRCT)", "summary": "This article analyzes the historical performance of Procept Biorobotics Corp (PRCT) stock, detailing how a $1,000 investment would have fared over different periods. It also provides an overview of the company's focus on surgical robotics for urology, specifically its AQUABEAM an", "url": "https://www.stocktitan.net/tools/stock-return-calculator/PRCT", "source_name": "Stock Titan", "published_at": "2026-07-03T00:09:46", "published_display": "03 Jul 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist cuts Procept BioRobotics stock rating on reimbursement concerns", "summary": "Truist Securities downgraded Procept BioRobotics Corp (NASDAQ:PRCT) to Hold from Buy and lowered its price target due to concerns over reimbursement for its Aquablation procedures. This downgrade follows a proposal from the Centers for Medicare and Medicaid Services to increase r", "url": "https://www.investing.com/news/analyst-ratings/truist-cuts-procept-biorobotics-stock-rating-on-reimbursement-concerns-93CH-4774243", "source_name": "Investing.com", "published_at": "2026-07-02T21:39:19", "published_display": "02 Jul 2026 21:39", "sentiment": "negative", "sentiment_pct": 27, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of PROCEPT BioRobotics Corp. \u2013 BX:PRCT", "summary": "This page displays the enterprise value to EBIT forward for PROCEPT BioRobotics Corp. (BX:PRCT). It is part of the financial data available for the company on the platform. The information is provided by various financial data services.", "url": "https://www.tradingview.com/symbols/BX-PRCT/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T08:09:50", "published_display": "02 Jul 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPLTlKbHdUREFLWTRmeUdGZm9oYW5CS25RbHVWcmxuM2ZoLWhicHJIMERPNVhfQVBabDFyOWxiNTd6TEtMbmNFRHpGWjhUc1ZFd0UxeTg5ODJJLUU4WXNkbXoyY1hLM21rdjBMbS1jUGxFMmxZV3VHZVZhWldDUGR5bnZsd2kwLUxOYmxCR1pTbkl2cXRpd0JBbnJxUzJKM1ZCckg4SnNuUlVqLXdWazNtWUpDX3hfOXRwejZsTUEyb29XWUp1WEVsVlNQbk1DTVFlLVdDNm1Yb9IB3AFBVV95cUxPUzB1djJJRVdYRE1NRllnU3NlcUxUNDZScFFtRmIyRzlVMTlXSXNmdHZsNzhoMWVSWlVYRkk3VjVNQ0N4cjNYdG9KemNJakZWdmN4eEowMFBnWUVQaVJ6UTJRT0tLM3dTT1lCR0xCUFpDdzR0NE5KZTdkZGJ3SkFXc2JVZWZsejBfV3l4U0tkcmYxdFV1dGZFMmlkaGE3MDNqdmZsNHJXTU45SzFKVVgwQzFNRlNZV210Z0dOejc5d2ROZ1kyNlRCZ3VTZW84WERSXzliWFZtUkxZczJN?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Is Up 7.2% After WATER IV Milestones Spotlight Aquablation\u2019s Oncology Potential \u2013 Has The Bull Case Changed?", "summary": "PROCEPT BioRobotics (PRCT) saw its stock rise by 7.2% following milestones in its WATER IV prostate cancer trials, suggesting Aquablation therapy could expand into urologic oncology. This development could broaden the company's market beyond benign prostatic hyperplasia, reinforc", "url": "https://www.sahmcapital.com/news/content/procept-biorobotics-prct-is-up-72-after-water-iv-milestones-spotlight-aquablations-oncology-potential-has-the-bull-case-changed-2026-07-01", "source_name": "Sahm", "published_at": "2026-07-01T05:41:27", "published_display": "01 Jul 2026 05:41", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Initiates PROCEPT BioRobotics (PRCT) At \u201cOutperform,\u201d Cites Aquablation Growth Potential", "summary": "Evercore ISI has initiated coverage on PROCEPT BioRobotics (PRCT) with an \"Outperform\" rating and a $30 price target, highlighting the potential of Aquablation therapy. The company recently achieved two significant milestones in its WATER IV prostate cancer clinical program, incl", "url": "https://www.insidermonkey.com/blog/evercore-initiates-procept-biorobotics-prct-at-outperform-cites-aquablation-growth-potential-1790977/?amp=1", "source_name": "Insider Monkey", "published_at": "2026-06-30T02:10:35", "published_display": "30 Jun 2026 02:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of PROCEPT BioRobotics Corp. \u2013 BX:PRCT", "summary": "This article provides financial data for PROCEPT BioRobotics Corp. (BX:PRCT), specifically focusing on its price-to-earnings forward metric. The content highlights the period, value, and change percentage of this financial indicator, noting that the data is provided by ICE Data S", "url": "https://www.tradingview.com/symbols/BX-PRCT/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T05:09:32", "published_display": "28 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of PROCEPT BioRobotics Corp. \u2013 BX:PRCT", "summary": "This article provides the \"Price to sales forward\" financial metric for PROCEPT BioRobotics Corp. (BX:PRCT) on the TradingView platform. It shows the company's ticker, exchange, and confirms that the market is currently closed with no trades. The data presented is stated as being", "url": "https://www.tradingview.com/symbols/BX-PRCT/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T02:39:52", "published_display": "28 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRCT Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for PROCEPT BioRobotics Corp. (PRCT) stock, based on analyst opinions. It highlights the current stock price, market capitalization, volatility, and details on past earnings, revenue, and upcoming earnings reports. Additionally, i", "url": "https://www.tradingview.com/symbols/BIVA-PRCT/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-28T01:10:50", "published_display": "28 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of PROCEPT BioRobotics Corp. \u2013 BX:PRCT", "summary": "This page displays the \"Price to book forward\" financial metric for PROCEPT BioRobotics Corp. (PRCT) on the BX Swiss exchange. It indicates that the financial data is 'Made by humans' and sources its market and reference data from ICE Data Services and FactSet, respectively. The ", "url": "https://www.tradingview.com/symbols/BX-PRCT/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T01:10:50", "published_display": "28 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BIOROBOTICS CORP (PRCT) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE1tQW9mRGVEeENaUGx1S0xrUFN2cV83Z1VPcjdFVzNvdnE5anp6VHZwaGJSSG9lQ19QVkVwdWQyQzEtcVBneFhhRUdyTUwxOHZHckd1YWJIMmdJS01QSlF0Wm9vRy0?oc=5", "source_name": "ChartMill", "published_at": "2026-06-27T00:21:28+00:00", "published_display": "27 Jun 2026 00:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right Now", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/why-procept-biorobotics-prct-amongst-060211529.html", "source_name": "Insider Monkey", "published_at": "2026-06-25T06:02:11+00:00", "published_display": "25 Jun 2026 06:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI initiates Procept BioRobotics stock with outperform rating", "summary": "Evercore ISI initiated coverage on Procept BioRobotics (NASDAQ:PRCT) with an outperform rating and a $30 price target, highlighting the company's strong long-term fundamentals despite short-term challenges. The firm believes Procept's Aquablation technology has superior clinical ", "url": "https://m.uk.investing.com/news/stock-market-news/evercore-isi-initiates-procept-biorobotics-stock-with-outperform-rating-93CH-4742028?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-25T02:10:48", "published_display": "25 Jun 2026 02:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Initiates Coverage on PROCEPT BioRobotics With Outperform Rating, $30 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/evercore-isi-initiates-coverage-procept-112650225.html", "source_name": "MT Newswires", "published_at": "2026-06-24T11:26:50+00:00", "published_display": "24 Jun 2026 11:26", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI initiates Procept BioRobotics stock with outperform rating By Investing.com", "summary": "Evercore ISI has initiated coverage on Procept BioRobotics (NASDAQ:PRCT) with an outperform rating and a $30.00 price target, citing the company's strong long-term fundamentals despite short-term challenges. The firm believes Procept's Aquablation technology has superior clinical", "url": "https://ca.investing.com/news/stock-market-news/evercore-isi-initiates-procept-biorobotics-stock-with-outperform-rating-93CH-4705021", "source_name": "Investing.com Canada", "published_at": "2026-06-24T10:40:17", "published_display": "24 Jun 2026 10:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Best Robotics and Automation Stocks to Invest In", "summary": "This article lists the top 5 robotics and automation stocks to consider for investment, highlighting PROCEPT BioRobotics Corp. as one of them. PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is praised for its advancements in prostate cancer treatment with its Aquablation therapy, partic", "url": "https://www.insidermonkey.com/blog/5-best-robotics-and-automation-stocks-to-invest-in-1787445/?amp=1", "source_name": "Insider Monkey", "published_at": "2026-06-24T03:30:00", "published_display": "24 Jun 2026 03:30", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20", "summary": "Bank of America has downgraded PROCEPT BioRobotics (PRCT) to 'Underperform' from 'Neutral' and cut its price target to $20 from $38, following the company's Q4 results which missed street estimates. Concerns were raised about earnings visibility, profitability, and execution, as ", "url": "https://stocktwits.com/news-articles/markets/equity/prct-stock-tumbles-pre-market-bof-a-questions-earnings-visibility-cuts-target-to-20/cZTGJmTRIbn", "source_name": "Stocktwits", "published_at": "2026-06-23T04:10:27", "published_display": "23 Jun 2026 04:10", "sentiment": "negative", "sentiment_pct": 20, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed?", "summary": "PROCEPT BioRobotics (PRCT) has experienced a 6.5% stock drop despite strong year-over-year revenue and net profit growth, coupled with a surge in institutional ownership exceeding total shares outstanding. The company's investment narrative centers on Aquablation becoming a stand", "url": "https://www.sahmcapital.com/news/content/procept-biorobotics-prct-is-down-65-after-institutional-ownership-surges-past-shares-outstanding-has-the-bull-case-changed-2026-06-23", "source_name": "Sahm", "published_at": "2026-06-22T13:40:17", "published_display": "22 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds", "summary": "Despite a recent stock decline, PROCEPT BioRobotics (PRCT) is considered 14% undervalued with a fair value of $25.26 per share, even though it currently trades at $21.72. Analyst commentary highlights rapid revenue growth, expanding gross margins, and lower management guidance. A", "url": "https://www.sahmcapital.com/news/content/procept-biorobotics-prct-stock-could-be-14-undervalued-after-growth-outlook-holds-2026-06-20", "source_name": "Sahm", "published_at": "2026-06-20T12:40:07", "published_display": "20 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPaVdpLVpqUGNzRkNyZDZHYk1WZE9NNmRGNjNxV0hRSzFHNW5jbmVac2FoZXFBMDBFUS1BdDF6eXd6dmVlZDF4a0hyYUhCVW9kOXljckFLRWNuNU5sNGNVUjB5c3NjcEpRU2NmLXJYcENocEFRMG5WcnlFc20wemM4eHF4a29vbHphVFlTREU3VVdEd3NZTmU4OUtrVEJBTW1jUjlVX2VZblQtUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top 3 Health Care Stocks You'll Regret Missing In Q2", "summary": "This article identifies three oversold health care stocks\u2014iRhythm Holdings, Anbio Biotechnology, and Procept Biorobotics\u2014that investors might regret missing in Q2. These companies are highlighted based on their Relative Strength Index (RSI) being near or below 30, indicating a po", "url": "https://www.sahmcapital.com/news/content/top-3-health-care-stocks-youll-regret-missing-in-q2-2026-06-18", "source_name": "Sahm", "published_at": "2026-06-19T00:09:30", "published_display": "19 Jun 2026 00:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Procept Biorobotics Corp (PRCT) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Procept Biorobotics Corp (PRCT), listing its major institutional holders like Fidelity Management & Research Company LLC, BlackRock, and AllianceBernstein. It provides a breakdown of shareholder types, institutional shareholding t", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prct/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T23:17:54", "published_display": "17 Jun 2026 23:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Procept Biorobotics Corp (PRCT) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Procept Biorobotics Corp (PRCT), detailing its current earnings forecast score, analyst ratings, and price targets. PRCT ranks 142 out of 203 in the Healthcare Equipment & Supplies industry with a \"Buy\" trend based on 15 analysts, and", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prct/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T20:40:24", "published_display": "17 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Procept Biorobotics stock sliding today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOeExtVmRLcGRJektYeUFETWtvLU0yV0VSV3MwRlZCaTJGRTRpS254bHhTang3dmFmenNSUkROZ0JFZmRFb3VoM2FRbTdPa1FvaDlId280VFUwMDh1cUtBZ1cyblJ1alROT2ZhNWR4QkU5MGJ5WE9aa3RpQUxhUnEtTUNtWHIyWFk1T1NkV29ET0N5c2o0QWhzSmplQlhCcnhuZ0I1c0N1a2ptaVl1?oc=5", "source_name": "Investing.com", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Shares Drop After Downgrade From Leerink Partners", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/procept-biorobotics-shares-drop-downgrade-181932865.html", "source_name": "MT Newswires", "published_at": "2026-06-11T18:19:32+00:00", "published_display": "11 Jun 2026 18:19", "sentiment": "negative", "sentiment_pct": 42, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) director receives RSU and option grants as equity pay", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQLXZUcmxjMDY4MFZiNG1aT2RuZ1JWdzVrMEZVdzhTbEhXSGJDOVJmTjRRUTl6N29OTU1Vc3BHN095d1ZJVHVqUDkyNTNOV1hwcWlEeGRWM0VWZ0F5UHV0WDY2S3A5VVlPZlVOWTNGQ1hMMGpyMHBfMTRuNUdIdGRXUUpXcVpUdU5LNVU3cFdybUFEYi1VbTQ0RnQtbTNoS1BpNUlFOXFzZU9mMFpySXZCNFR5SW9sQV82eldN?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Amy Dodrill receives RSUs and options at PROCEPT (NASDAQ: PRCT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNRkt6X3FYbDQ1ZzdmTTlIX1pZa2xkWUhzRU0xVHMxaDJsVS1lN3BsbENjN29xaUVKNFoyTnI5MmNUUDBRalFRdWM4MnV5YkJJUk13bnQ5dVVVLThPTTJjaE1DbHF2SDRZSnA3YTVJUlZFTGNaMlRNcjhQT0tEaXVyNFRieVNvTDdEVmJ2T2k3bl9LRkdRNDduenhoQkFDbWpEMDN1Ym5uR085dkE5cXk3ZnoxOGJ1emEwNE1v?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV Milestones - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQSm9RamlsWXlDZmhCN01FMWpEbEhKOFlFdWlVUk5NbVRhd3NvR21iUnNGOEpoS296MTljanFYSGJGTmNabUVCcGhkWGJ2QnJUNWVmanh5MGgxaFlkZHU1Unp5VE0wNkk5R3FLR1NwbTZIUlNiSmdLSWdjQV9OU1E2N0VxWFVxVEVrc3BYZWRqblNlbm5zRUV0VVNTZWRaemF5cXc?oc=5", "source_name": "Market source", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPaDZ0RVIwZHNGT29pNXJwVGRFU1oySGpDY2hpazVFbEt1bDFUczF5VmtMVGU3MmlGZnFkQTRlSnBFaE41Uk1jYzJja0FkeVE5WDJIYzd1MHA5RlpBd09mb0ZWZ1AxMk1FbXZCeHk3QUQxd2xpbldzZFAtX0F3WXhFNjRQLU1wTVdKaFZ0QWJ6VGxsUmdMSUljTk45ZXIzd1YtU3ZhV3RJbWpUNVprSklF?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Results Say a Lot About Procept Biorobotics Corp (PRCT) Stock Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQN05oTzBBVk53RnU3S0xQRXljQkJHTHAwVTdlNDJ6Unk4aWJ2RkZ1YjZFMWYzQ25uMlhRVGlYRmtqVmJkejFNNjhEdXhwczNtMWczRlpEUmdhR3dUb1V5SlhaXzhQdjJPZmlHdmQ0UU53RFBtdXZtUDVEWEt4UXh6bHF2R2J2RF9NbFc1aGg4RndjeTNnZGhWTUwySjRIb0dy?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics schedules 3 investor conference appearances", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPWVhnQi1iYnhvYUtSaFIxVzBuZlBJU3Fha3d4SlFMX2sxUTdZRHZlM1RlcDlfTEtuMkNDRFVZNDFMVkYxbnB6YWhkNjdhZjB1RFltbHdhcGU1YlgzemU1aVhaVkdhWUFhQzNyTlptSklqcnNuUHV3ZU5BN3l4bkVpX0ZQTVBleVkzLUp0MzhsS1Y5R0FYcUlJQlRBai1CX3c3bUhwYTlPMGlSVUFpNmdHdEhRY1RSWG1VNG51bHR3?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNb1BRZ3dYS1VZVklMQ0JIYTZyLXl1dncwOWswRnlDcHZRTkdKU3c4RXNUaHdOeE9XQkNtWmFrVWZnYW5GQW81d0dvcU5Cc0FZWS1rQWs2bmxXRlNKR0xNRkhDQm9OdktrRFl2LWNRNU5NNmlwZWtZVnZJZHdRd3NibWplSVRwazBYcTBWYlBweGI5X0ZHUWMtY0hLM0lqTHRQMjc0ZUJyTV9nQWVlVV9VUWE4Qm9ZRFpYc2pyNmkzWHZLb0NYcE9sWC1tU2hRNGw3Wnc?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPdTFnTzlrTndFNHJpR01tN0llNWUwZmtEeExSS0tZdkhsSEVvQy1UcGdHRjJNSE11UHgzS05RSHhyWXo5Tmd5S2RTb2lnRm5uZG9va0ctbkZwNzJuQWlCbXR5WWtlSzd6Tnd0aGZXOXowaTJfdFk3S3FSZlRmVkhScm9Qa25UQjlrQTdKMlNjQ2M3d1ZQSzNPdW5IU0o0ZkZ3UU5ST2FFUl95R3NpOGhqazFmMA?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Resets Commercial Model To Pursue Higher Quality Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At PROCEPT BioRobotics (PRCT) Valuation After Q4 Revenue Miss And Softer 2026 Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQd1VPVVQwX0ctcnpXc0xoZzg0NHRUNXJyQ0p1UnhaazhBWUNRZG5PTUxnUVJFSnd3U19BYktRNFMtc2RoWHduMjlma2wyaHg5MHJfcTFBemlsNGFZNDlaeUU4em01MFFib2h0S1ZSZDdfbmNZcFBRY0xydThzMVQ1cWdyTUMxUDc4QUdOWmVB?oc=5", "source_name": "Market source", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Details Growth Strategy and Financial Outlook During 2026 Investor Day Event", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQd3pvd1U5cWdaZUlKMGJEX0dkRUVPX3dwWG9jaUFSbi12STQxbGEzTUZjNkgwM09LUXVWbk9nMmt2NnpMUEt1bEd6VzNPNFo3NkVPY3A5eXEtbWVHeS1DbVNPamJvUVpqa0djajh4aXRnZG1JaEM4NW1MT1Y0VkI3RFU0ZkcwQVUzRHRsRE9BeURzcGswT1R3bVFsaGtxLW9BODZrMDNmR2Rwa3c1bFFCczZFdjhibFZEYXZ2TXdmeDhHVVlCZ3lCVg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQSFJDeEhkanRlbzc0TktkcHZvbVVPRm55ejZKOW1zdEw0YzY5R25kV0dRY1JRV3ZJbTdPYl85QkVjZDFXbGhTQ1VrT0V5eUxVMmhVRENBeVZ5OEtvR0NrQl95X1V4ODBjQ1YtMS1mY0pHYkwwZEMxV2N0UFA2MHExb1R4UmpTZURnMTE2S184dUw3RmZKNThRc3czLTRRM05WaHR5aU5jUk9tMmZRN1RiV0pUWHZFTVVFMUVyZWFnUVFwX2xyT3p1cldYVUp0bkdoX0NIaWNZbGlxdDhYc3FZUS1HNUo1Z21BZUdpTUhHaG10QVFidUt4VGpLdkZPaWIt?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics Corporation (PRCT): A Bull Case Theory", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNeFRiMkxWV2NmR05iRXlNNmNJV0FNNURYck9USXNkYWFuVHpjREZQRGU3ZnlvQ1BNNVZqSmNTem1wYnNjX001YmZHMEZXdjJwNWN1NXBKcGtIcVFRU0RfZTlERUJRUGk5UExTX2FhaUhQTWVhbU44bzF5Z0JETld5RndIaTMybnMxUTVDVWRfbVI?oc=5", "source_name": "Market source", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Has a Positive Opinion on \u200bPROCEPT BioRobotics (PRCT), Here\u2019s Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQRjZ0TDcwRFNYYWRLZ1ZkZTdtQUYxSHVsSFRXc0tDdlF2ZjluOVVRM0JIckRFOVl2THJRM2cwZ19ONUROaklZMWxLaFpQSGlVeng5dnNJMEw5Sy1tNWpuN0lfakFGcWNGSlZRTThqYktWc1dyRXlMeHJ3MW5OZ1ZyRDFWT3ZMVlYzRUE?oc=5", "source_name": "Market source", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At PROCEPT BioRobotics (PRCT) Valuation After Mixed Recent Share Price Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPWHFMMVg1QWROWHVGb2JUcy1meUhpWDJpN1ZYdGlaT0lRVWgtZWxYNkxETjZoLUlmbDE2ak5EcU5pSlRRTV9kME9CZkNkTlVFVjM3bTF0djUtWThrT2NKMkp1OHlvRTF3S2tXYlJDSzQzY3BfaWZmeTk2YjV3SFRNYzl1YWo5aERKMklfQXd3?oc=5", "source_name": "Market source", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROCEPT BioRobotics to Report Q4 2025 Financial Results and Host Investor Day Event in February 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNQXVUOWlrdm91dmY5N2dhWjdiaU10a1dPTU1DY3ZmUHVYaXJKV1VTOXEtRXJrV0kycEx4eHh5MjJRMFpWTDhSTGplZ05ybnJSXzFDcW1Za2YxeW5FeXZRRlZRZHJTbmVtd3NvNXZreFV2d3gtODJ2NlNnWXVJbG9PVEs1ekJyM0FEQlNXQ1VoRVNESFcyUUNhSWZTbllTV1R1S0VtX2NOVnFNM1MzcnNJQWlxX1hxYTZfYmJfSnV3dl9jYm9oaEFQaXVoNkFyUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-01-26T08:00:00+00:00", "published_display": "26 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQZXhDWktWZlhhSHlxNVZrNWllaDhhWlNXZmhKYlQ4ODRJMHozNTR2TVVKSWVrQV94bzNNU0hfVW5qODRlWW01anFmTG5SYmZoUlJpU09UbkpSemxVbHRGb1F1MGVvZFdqSEVBcUZ5Ti1ZVHlzY3pZYTdCS21RcDJPTnppdWRKVlZjd2ZUeA?oc=5", "source_name": "Market source", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 101, "total_relevant": 67, "sentiment_summary": {"positive": 16, "negative": 12, "neutral": 39, "score": 51, "total": 67, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 17.05, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 12.37, "count": 25}, {"event": "analyst", "label": "Analyst action", "weight": 4.95, "count": 9}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}], "positive_events": 16, "negative_events": 12}, "market_context": {"has_market_context": true, "latest_close": 20.89, "latest_week": "2026-07-10", "one_week_move": -0.7, "four_week_move": -18.7, "twelve_week_move": -16.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.05587, "market_dynamics_buy_signal": false, "relative_strength": -44.024438, "fair_value_gap": -57.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 44.5835, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.7% over one week, -18.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 48, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 18}, {"label": "Stock Titan", "count": 5}, {"label": "TradingView", "count": 5}, {"label": "Sahm", "count": 4}, {"label": "MT Newswires", "count": 3}, {"label": "Investing.com", "count": 3}, {"label": "Insider Monkey", "count": 3}, {"label": "simplywall.st", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 57}, {"label": "Industry context", "count": 10}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 25}, {"label": "Analyst action", "count": 9}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "57", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.7% over one week, -18.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Procept Biorobotics Corp stock hits 52-week low at 19.2 USD"}], "updated_at": "2026-07-18T08:47:07.072930+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}